(78 days)
THE MINOP® DISPOSABLE INTRODUCER IS INDICATED TO OBTAIN AND MAINTAIN A TEMPORARY PATHWAY INTO THE VENTRICULAR SYSTEM OF THE BRAIN.
The MINOP® Disposable Introducer is a single used to obtain ventricular access and facilitate endoscope insertion. The MINOP® Disposable Introducer consists of an introducer sheath and a ventricular obturator.
The document provided is a 510(k) premarket notification for the MINOP® Disposable Introducer. This type of submission relies on demonstrating substantial equivalence to a predicate device rather than comprehensive clinical studies with detailed acceptance criteria and standalone performance metrics typically associated with AI/ML device evaluations.
Therefore, many of the requested categories related to AI/ML device studies (such as MRMC studies, training set details, expert qualifications for ground truth, etc.) are not applicable to this submission.
Here's a breakdown of the available information based on your request:
1. Table of Acceptance Criteria and Reported Device Performance
The document does not explicitly state formal acceptance criteria in a quantitative table for multiple performance metrics. Instead, it refers to equivalence to a predicate device and internal standards for peel force.
| Feature/Test | Acceptance Criteria (or Comparison) | Reported Device Performance |
|---|---|---|
| Peel Force | Meets requirements defined in Medcomp's internal standards for force at break (of the sheath). | "Results of the peel force testing meet the requirements defined in Medcomp's internal standards for force at break." (The document states the MINOP® Disposable Introducer's sheath design (with ink depth markings) and obturator tip rounding do not affect the peel force relative to the predicate.) |
| Material | Substantially equivalent to Medcomp Vascu-Sheath® Introducer Set. | The document states "sheath are identical to the legally marketed Medcomp device." |
| Design | Substantially equivalent to Medcomp Vascu-Sheath® Introducer Set. | Minor differences: obturator has a rounded tip, sheath has ink depth markings. These were deemed not to affect peel force. |
| Sterilization | Substantially equivalent to Medcomp Vascu-Sheath® Introducer Set. | Not explicitly detailed, but implied by the claim of substantial equivalence. |
| Indications for Use | Equivalent to Medtronic PS Medical Endoscope Introducer. | "The MINOP® Disposable Introducer is indicated to obtain and maintain a temporary pathway into the ventricular system of the brain." |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: Not specified in the document. The performance data section vaguely refers to "Performance testing" and "Results of the peel force testing" without giving specific numbers of units tested.
- Data Provenance: The testing was "in-vitro" and relates to the physical properties of the device components. There is no information regarding country of origin or whether it was retrospective or prospective, as it's not a clinical study involving patient data.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications
Not Applicable. This is an invivo mechanical/material performance test, not a study requiring expert readers to establish ground truth. The "ground truth" here is the physical measurement of peel force against defined internal standards.
4. Adjudication Method for the Test Set
Not Applicable. There's no "adjudication" in the sense of reconciling divergent expert opinions, as this is a physical performance test.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done
No. An MRMC study was not done. The submission relies on substantial equivalence to predicate devices, supported by in-vitro mechanical testing.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Study Was Done
Not Applicable. This is a physical medical device, not an AI/ML algorithm.
7. The Type of Ground Truth Used
The ground truth used for the peel force analysis was "Medcomp's internal standards for force at break." This refers to a predefined, objective standard for mechanical performance.
8. The Sample Size for the Training Set
Not Applicable. This device did not involve machine learning; therefore, there was no training set.
9. How the Ground Truth for the Training Set Was Established
Not Applicable. As there was no training set, this question is not relevant.
{0}------------------------------------------------
A. Submitter Information:
| Submitter: | Aesculap, Inc.3773 Corporate ParkwayCenter Valley, PA 18034Tel: (610) 984-9072Fax: (610) 791-6882 | JUL 1 1 2006 |
|---|---|---|
| Contact: | Matthew M. HullRegulatory Affairs Manager | |
| Date Prepared: | 11 April 2006 | |
| Trade Name: | MINOP® Disposable Introducer | |
| Common Name: | Endoscope Introducer | |
| Classification: | GYK | |
| C.F.R. Section: | 882.4545 | |
| Class: | II | |
| Predicate Devices: | K022513 Medcomp Vascu-Sheath®Introducer SetK990333 Medtronic PS Medical EndoscopeIntroducer |
D. Device Description:
The MINOP® Disposable Introducer is a single used to obtain ventricular access and facilitate endoscope insertion. The MINOP® Disposable Introducer consists of an introducer sheath and a ventricular obturator.
E. Intended Use:
B.
C.
The MINOP® Disposable Introducer is indicated to obtain and maintain a temporary pathway into the ventricular system of the brain.
F. Comparison to Predicate Device:
The technological characteristics of the MINOP® Disposable Introducer are substantially equivalent to the predicate devices. The proposed device is equivalent to the Medcomp Vascu-Sheath® Introducer Set in terms of design, materials, performance and sterilization; while the only differences are the indications for use, the obturator of the proposed device has a rounded tip, and its sheath has ink depth markings. The proposed device is equivalent to the Medtronic PS Medical Endoscope Introducer in regard to the indications for use.
G. Performance Data:
Performance testing was performed on the peel force of the sheath for the Medcomp Vascu-Sheath® predicate device; the only sheath design change between this device and the proposed device is the addition of ink depth markings, which do not affect the peel force of the sheath. The rounding of the obturator tip on the proposed device also has no bearing on the peel force of the sheath. All other aspects of the obturator and
{1}------------------------------------------------
sheath are identical to the legally marketed Medcomp device. Results of the peel force testing meet the requirements defined in Medcomp's internal standards for force at break.
Clinical studies were not deemed necessary since in-vitro testing was sufficient to demonstrate safety and effectiveness by way of comparison to the legally marketed predicate device.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health and Human Services (HHS). The seal features the department's name encircling a stylized caduceus, a symbol often associated with medicine and healthcare. The text reads "DEPARTMENT OF HEALTH AND HUMAN SERVICES. USA" around the image. The caduceus is depicted with a staff entwined by two snakes.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 1 1 2006
Aesculap, Inc. % Medcomp Ms. Lisa Weikert Regulatory Specialist 1499 Delp Drive Harleysville, Pennsylvania 19438
Re: K061135
Trade/Device Name: MINOP® Disposable Introducer Regulation Number: 21 CFR 882.1480 Regulation Name: Neurological endoscope Regulatory Class: II Product Code: GWG Dated: June 13, 2006 Received: June 14, 2006
Dear Ms. Weikert:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
{3}------------------------------------------------
Page 2 - Ms. Lisa Weikert
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
J. Herbert Vennmo
Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
Indications for Use
510(k) Number (if known): _ 长いんしけろう
Device Name: MINOP® Disposable Introducer
Indications for Use:
THE MINOP® DISPOSABLE INTRODUCER IS INDICATED TO OBTAIN AND MAINTAIN A TEMPORARY PATHWAY INTO THE VENTRICULAR SYSTEM OF THE BRAIN.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Eyaluation (ODE)
Hulut Leun
(Division Sign-Off) Division of General, Restorative, and Neurological Devices
510(k) Number K061135
§ 882.1480 Neurological endoscope.
(a)
Identification. A neurological endoscope is an instrument with a light source used to view the inside of the ventricles of the brain.(b)
Classification. Class II (performance standards).